Loading…

Cytoplasmic initiation of cisplatin cytotoxicity

The mechanism of action of cisplatin as a chemotherapeutic agent has been attributed to DNA binding, while its mechanism of action as a nephrotoxin is unresolved. Only approximately 1% of intracellular cisplatin interacts with DNA, primarily forming intrastrand cross-linked adducts, and many studies...

Full description

Saved in:
Bibliographic Details
Published in:American Journal of Physiology. Renal Physiology 2008-07, Vol.295 (1), p.F44-F52
Main Authors: Yu, Fang, Megyesi, Judit, Price, Peter M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c518t-4c5a9f5b74d5286f62567b98efed6cf5b84683771efbe9c0ee7973edc6ec85453
cites cdi_FETCH-LOGICAL-c518t-4c5a9f5b74d5286f62567b98efed6cf5b84683771efbe9c0ee7973edc6ec85453
container_end_page F52
container_issue 1
container_start_page F44
container_title American Journal of Physiology. Renal Physiology
container_volume 295
creator Yu, Fang
Megyesi, Judit
Price, Peter M
description The mechanism of action of cisplatin as a chemotherapeutic agent has been attributed to DNA binding, while its mechanism of action as a nephrotoxin is unresolved. Only approximately 1% of intracellular cisplatin interacts with DNA, primarily forming intrastrand cross-linked adducts, and many studies have implicated both nuclear and cytoplasmic causes of cisplatin-induced death in cultured cells. We have demonstrated that cisplatin cytotoxicity depends on cdk2 activity, which is at least partly through the cdk2-E2F1 pathway. The mechanism of the dependency on cdk2, and whether cdk2 activation of E2F1 represents the only cell death pathway involved, is still unclear. Our previous work showed that deletion of the nuclear localization signal from p21 WAF1/CIP1, a cdk2 inhibitor, did not alter its protective action against cisplatin cytotoxicity. Active cdk2-cyclin complexes are localized in both the nucleus and cytoplasm, and it was reported that cdk2 translocated to the cytoplasm after an apoptotic stimulus. Herein, we show that cisplatin caused cell death in enucleated mouse kidney proximal tubule cells (TKPTS), which was prevented by cdk2 inhibition. Also, we localized cytoplasmic cdk2 to both the endoplasmic reticulum (ER) and Golgi compartments, and ER stress was blocked by specific cdk2 inhibition. We conclude that cisplatin can induce nuclear independent apoptosis, cisplatin cytotoxicity can be initiated by cytoplasmic events, and cytoplasmic cdk2 plays an important role in apoptosis signaling.
doi_str_mv 10.1152/ajprenal.00593.2007
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2494516</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1512871091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c518t-4c5a9f5b74d5286f62567b98efed6cf5b84683771efbe9c0ee7973edc6ec85453</originalsourceid><addsrcrecordid>eNpVkElLAzEYhoMotlZ_gSDF-9Tsy0WQ4gYFLwreQibNaMp0Miap2H9vaut2Ssi7fF8eAE4RnCDE8IVZ9NF1pp1AyBSZYAjFHhgWBVeIcr5f7oqgSjLxPABHKS0ghAhhdAgGSFIIJVdDAKfrHPrWpKW3Y9_57E32oRuHZmx9KkL23dgWTw4f3vq8PgYHjWmTO9mdI_B0c_04vatmD7f306tZZRmSuaKWGdWwWtA5w5I3HDMuaiVd4-bcFkFSLokQyDW1UxY6J5Qgbm65s5JRRkbgctvbr-pleXddjqbVffRLE9c6GK__K51_1S_hXWOqKEO8FJzvCmJ4W7mU9SKsYuGVNCYQ4fJ_XExka7IxpBRd8zMAQb2hrL8p6y_KekO5pM7-7vab2WEln0oKfHk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230120862</pqid></control><display><type>article</type><title>Cytoplasmic initiation of cisplatin cytotoxicity</title><source>American Physiological Society Free</source><creator>Yu, Fang ; Megyesi, Judit ; Price, Peter M</creator><creatorcontrib>Yu, Fang ; Megyesi, Judit ; Price, Peter M</creatorcontrib><description>The mechanism of action of cisplatin as a chemotherapeutic agent has been attributed to DNA binding, while its mechanism of action as a nephrotoxin is unresolved. Only approximately 1% of intracellular cisplatin interacts with DNA, primarily forming intrastrand cross-linked adducts, and many studies have implicated both nuclear and cytoplasmic causes of cisplatin-induced death in cultured cells. We have demonstrated that cisplatin cytotoxicity depends on cdk2 activity, which is at least partly through the cdk2-E2F1 pathway. The mechanism of the dependency on cdk2, and whether cdk2 activation of E2F1 represents the only cell death pathway involved, is still unclear. Our previous work showed that deletion of the nuclear localization signal from p21 WAF1/CIP1, a cdk2 inhibitor, did not alter its protective action against cisplatin cytotoxicity. Active cdk2-cyclin complexes are localized in both the nucleus and cytoplasm, and it was reported that cdk2 translocated to the cytoplasm after an apoptotic stimulus. Herein, we show that cisplatin caused cell death in enucleated mouse kidney proximal tubule cells (TKPTS), which was prevented by cdk2 inhibition. Also, we localized cytoplasmic cdk2 to both the endoplasmic reticulum (ER) and Golgi compartments, and ER stress was blocked by specific cdk2 inhibition. We conclude that cisplatin can induce nuclear independent apoptosis, cisplatin cytotoxicity can be initiated by cytoplasmic events, and cytoplasmic cdk2 plays an important role in apoptosis signaling.</description><identifier>ISSN: 1931-857X</identifier><identifier>ISSN: 0363-6127</identifier><identifier>EISSN: 1522-1466</identifier><identifier>DOI: 10.1152/ajprenal.00593.2007</identifier><identifier>PMID: 18400869</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Animals ; Antineoplastic Agents - toxicity ; Apoptosis ; Binding sites ; Cell Compartmentation ; Cell culture ; Cell Nucleus - physiology ; Cells, Cultured ; Chemotherapy ; Cisplatin - toxicity ; Cyclin-Dependent Kinase 2 - antagonists &amp; inhibitors ; Cyclin-Dependent Kinase 2 - metabolism ; Cytoplasm - physiology ; Deoxyribonucleic acid ; DNA ; Endoplasmic Reticulum - metabolism ; Golgi Apparatus - metabolism ; Kidney Tubules, Proximal - cytology ; Kidney Tubules, Proximal - drug effects ; Kidneys ; Mice ; Recombinant Fusion Proteins - metabolism</subject><ispartof>American Journal of Physiology. Renal Physiology, 2008-07, Vol.295 (1), p.F44-F52</ispartof><rights>Copyright American Physiological Society Jul 2008</rights><rights>Copyright © 2008, American Physiological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c518t-4c5a9f5b74d5286f62567b98efed6cf5b84683771efbe9c0ee7973edc6ec85453</citedby><cites>FETCH-LOGICAL-c518t-4c5a9f5b74d5286f62567b98efed6cf5b84683771efbe9c0ee7973edc6ec85453</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18400869$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yu, Fang</creatorcontrib><creatorcontrib>Megyesi, Judit</creatorcontrib><creatorcontrib>Price, Peter M</creatorcontrib><title>Cytoplasmic initiation of cisplatin cytotoxicity</title><title>American Journal of Physiology. Renal Physiology</title><addtitle>Am J Physiol Renal Physiol</addtitle><description>The mechanism of action of cisplatin as a chemotherapeutic agent has been attributed to DNA binding, while its mechanism of action as a nephrotoxin is unresolved. Only approximately 1% of intracellular cisplatin interacts with DNA, primarily forming intrastrand cross-linked adducts, and many studies have implicated both nuclear and cytoplasmic causes of cisplatin-induced death in cultured cells. We have demonstrated that cisplatin cytotoxicity depends on cdk2 activity, which is at least partly through the cdk2-E2F1 pathway. The mechanism of the dependency on cdk2, and whether cdk2 activation of E2F1 represents the only cell death pathway involved, is still unclear. Our previous work showed that deletion of the nuclear localization signal from p21 WAF1/CIP1, a cdk2 inhibitor, did not alter its protective action against cisplatin cytotoxicity. Active cdk2-cyclin complexes are localized in both the nucleus and cytoplasm, and it was reported that cdk2 translocated to the cytoplasm after an apoptotic stimulus. Herein, we show that cisplatin caused cell death in enucleated mouse kidney proximal tubule cells (TKPTS), which was prevented by cdk2 inhibition. Also, we localized cytoplasmic cdk2 to both the endoplasmic reticulum (ER) and Golgi compartments, and ER stress was blocked by specific cdk2 inhibition. We conclude that cisplatin can induce nuclear independent apoptosis, cisplatin cytotoxicity can be initiated by cytoplasmic events, and cytoplasmic cdk2 plays an important role in apoptosis signaling.</description><subject>Animals</subject><subject>Antineoplastic Agents - toxicity</subject><subject>Apoptosis</subject><subject>Binding sites</subject><subject>Cell Compartmentation</subject><subject>Cell culture</subject><subject>Cell Nucleus - physiology</subject><subject>Cells, Cultured</subject><subject>Chemotherapy</subject><subject>Cisplatin - toxicity</subject><subject>Cyclin-Dependent Kinase 2 - antagonists &amp; inhibitors</subject><subject>Cyclin-Dependent Kinase 2 - metabolism</subject><subject>Cytoplasm - physiology</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Endoplasmic Reticulum - metabolism</subject><subject>Golgi Apparatus - metabolism</subject><subject>Kidney Tubules, Proximal - cytology</subject><subject>Kidney Tubules, Proximal - drug effects</subject><subject>Kidneys</subject><subject>Mice</subject><subject>Recombinant Fusion Proteins - metabolism</subject><issn>1931-857X</issn><issn>0363-6127</issn><issn>1522-1466</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNpVkElLAzEYhoMotlZ_gSDF-9Tsy0WQ4gYFLwreQibNaMp0Miap2H9vaut2Ssi7fF8eAE4RnCDE8IVZ9NF1pp1AyBSZYAjFHhgWBVeIcr5f7oqgSjLxPABHKS0ghAhhdAgGSFIIJVdDAKfrHPrWpKW3Y9_57E32oRuHZmx9KkL23dgWTw4f3vq8PgYHjWmTO9mdI_B0c_04vatmD7f306tZZRmSuaKWGdWwWtA5w5I3HDMuaiVd4-bcFkFSLokQyDW1UxY6J5Qgbm65s5JRRkbgctvbr-pleXddjqbVffRLE9c6GK__K51_1S_hXWOqKEO8FJzvCmJ4W7mU9SKsYuGVNCYQ4fJ_XExka7IxpBRd8zMAQb2hrL8p6y_KekO5pM7-7vab2WEln0oKfHk</recordid><startdate>20080701</startdate><enddate>20080701</enddate><creator>Yu, Fang</creator><creator>Megyesi, Judit</creator><creator>Price, Peter M</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20080701</creationdate><title>Cytoplasmic initiation of cisplatin cytotoxicity</title><author>Yu, Fang ; Megyesi, Judit ; Price, Peter M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c518t-4c5a9f5b74d5286f62567b98efed6cf5b84683771efbe9c0ee7973edc6ec85453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - toxicity</topic><topic>Apoptosis</topic><topic>Binding sites</topic><topic>Cell Compartmentation</topic><topic>Cell culture</topic><topic>Cell Nucleus - physiology</topic><topic>Cells, Cultured</topic><topic>Chemotherapy</topic><topic>Cisplatin - toxicity</topic><topic>Cyclin-Dependent Kinase 2 - antagonists &amp; inhibitors</topic><topic>Cyclin-Dependent Kinase 2 - metabolism</topic><topic>Cytoplasm - physiology</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Endoplasmic Reticulum - metabolism</topic><topic>Golgi Apparatus - metabolism</topic><topic>Kidney Tubules, Proximal - cytology</topic><topic>Kidney Tubules, Proximal - drug effects</topic><topic>Kidneys</topic><topic>Mice</topic><topic>Recombinant Fusion Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yu, Fang</creatorcontrib><creatorcontrib>Megyesi, Judit</creatorcontrib><creatorcontrib>Price, Peter M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American Journal of Physiology. Renal Physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yu, Fang</au><au>Megyesi, Judit</au><au>Price, Peter M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cytoplasmic initiation of cisplatin cytotoxicity</atitle><jtitle>American Journal of Physiology. Renal Physiology</jtitle><addtitle>Am J Physiol Renal Physiol</addtitle><date>2008-07-01</date><risdate>2008</risdate><volume>295</volume><issue>1</issue><spage>F44</spage><epage>F52</epage><pages>F44-F52</pages><issn>1931-857X</issn><issn>0363-6127</issn><eissn>1522-1466</eissn><abstract>The mechanism of action of cisplatin as a chemotherapeutic agent has been attributed to DNA binding, while its mechanism of action as a nephrotoxin is unresolved. Only approximately 1% of intracellular cisplatin interacts with DNA, primarily forming intrastrand cross-linked adducts, and many studies have implicated both nuclear and cytoplasmic causes of cisplatin-induced death in cultured cells. We have demonstrated that cisplatin cytotoxicity depends on cdk2 activity, which is at least partly through the cdk2-E2F1 pathway. The mechanism of the dependency on cdk2, and whether cdk2 activation of E2F1 represents the only cell death pathway involved, is still unclear. Our previous work showed that deletion of the nuclear localization signal from p21 WAF1/CIP1, a cdk2 inhibitor, did not alter its protective action against cisplatin cytotoxicity. Active cdk2-cyclin complexes are localized in both the nucleus and cytoplasm, and it was reported that cdk2 translocated to the cytoplasm after an apoptotic stimulus. Herein, we show that cisplatin caused cell death in enucleated mouse kidney proximal tubule cells (TKPTS), which was prevented by cdk2 inhibition. Also, we localized cytoplasmic cdk2 to both the endoplasmic reticulum (ER) and Golgi compartments, and ER stress was blocked by specific cdk2 inhibition. We conclude that cisplatin can induce nuclear independent apoptosis, cisplatin cytotoxicity can be initiated by cytoplasmic events, and cytoplasmic cdk2 plays an important role in apoptosis signaling.</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>18400869</pmid><doi>10.1152/ajprenal.00593.2007</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1931-857X
ispartof American Journal of Physiology. Renal Physiology, 2008-07, Vol.295 (1), p.F44-F52
issn 1931-857X
0363-6127
1522-1466
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2494516
source American Physiological Society Free
subjects Animals
Antineoplastic Agents - toxicity
Apoptosis
Binding sites
Cell Compartmentation
Cell culture
Cell Nucleus - physiology
Cells, Cultured
Chemotherapy
Cisplatin - toxicity
Cyclin-Dependent Kinase 2 - antagonists & inhibitors
Cyclin-Dependent Kinase 2 - metabolism
Cytoplasm - physiology
Deoxyribonucleic acid
DNA
Endoplasmic Reticulum - metabolism
Golgi Apparatus - metabolism
Kidney Tubules, Proximal - cytology
Kidney Tubules, Proximal - drug effects
Kidneys
Mice
Recombinant Fusion Proteins - metabolism
title Cytoplasmic initiation of cisplatin cytotoxicity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T13%3A28%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cytoplasmic%20initiation%20of%20cisplatin%20cytotoxicity&rft.jtitle=American%20Journal%20of%20Physiology.%20Renal%20Physiology&rft.au=Yu,%20Fang&rft.date=2008-07-01&rft.volume=295&rft.issue=1&rft.spage=F44&rft.epage=F52&rft.pages=F44-F52&rft.issn=1931-857X&rft.eissn=1522-1466&rft_id=info:doi/10.1152/ajprenal.00593.2007&rft_dat=%3Cproquest_pubme%3E1512871091%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c518t-4c5a9f5b74d5286f62567b98efed6cf5b84683771efbe9c0ee7973edc6ec85453%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=230120862&rft_id=info:pmid/18400869&rfr_iscdi=true